CRISPR Therapeutics (NasdaqGM:CRSP) witnessed a notable 25% gain over the past week, gaining traction amid an executive departure. The announcement of COO Julianne Bruno’s exit could have influenced ...

CRISPR Therapeutics experienced an 12% price decline ... respectively. The recent announcement of the COO's resignation was likely a contributing factor to the decline, adding uncertainty around ...

CRISPR Therapeutics (NasdaqGM:CRSP) experienced an 12% price decline over the last week, coinciding with significant market disruption driven by escalating tariff tensions, which saw the S&P 500 and ...

US stocks tumbled to their lowest levels in over six months as worries over new tariffs weighed on investor sentiment. With fears of a global slowdown and rising inflation, the S&P 500 and Nasdaq saw ...

Technology stocks were hit hardest, with Nvidia tumbling 5.3%, Microsoft plummeting 12.6%, and Tesla sliding 7% after Stifel slashed its delivery forecast.

The S&P 500 and the Nasdaq hit more than six-month lows on Monday as investors steered clear of risk-laden assets on worries over the Trump administration's upcoming announcement of extensive tariff ...

U.S. stock index futures tumbled on Monday as investors shied away from risky assets amid mounting concerns that the Trump administration's upcoming announcement of extensive tariff plans could hurt ...

Raches was six and his sister Jalachari 11 when their father, Krishna M. Ella, decided to leave his job as a faculty member ...

The ease of reprogramming Cas9 target sites has made it so popular and has ushered in a wave of potential genome editing therapeutics. However, despite the abundance of bacterial CRISPR-Cas9 ... As ...